Role of AMP-activated protein kinase in bacterial endophthalmitis
AMP 激活蛋白激酶在细菌性眼内炎中的作用
基本信息
- 批准号:9899998
- 负责人:
- 金额:$ 38.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdenosine MonophosphateAdoptedAdoptive TransferAgingAnti-Inflammatory AgentsAreaBacteriaBacterial Antibiotic ResistanceBioenergeticsBlindnessBone MarrowCellsCharacteristicsChemicalsChimera organismCitric Acid CycleComplicationCyclic AMP-Dependent Protein KinasesDevelopmentDiseaseDisease ProgressionEndophthalmitisEnergy MetabolismEventExhibitsEye InfectionsFunctional disorderGenesGenus HippocampusGlycolysisGoalsHost DefenseHumanImmuneImmune responseInfectionInfiltrationInflammationInflammation MediatorsInflammatoryInflammatory ResponseInterleukin-1 betaInterleukin-10Interleukin-6InvestigationKnock-outKnockout MiceLeadLightLinkMediatingMediator of activation proteinMetabolicMetabolismMicrogliaMitochondriaModelingModificationMolecularMusMyeloid CellsNatural ImmunityNatureNitric OxideOperative Surgical ProceduresOxidative PhosphorylationPTGS2 genePTPRC genePathogenesisPathologyPathway interactionsPharmacologyPhasePhenotypePhosphorylationPopulationPrevalencePreventionProductionProtein KinaseReportingResolutionRetinaRibonucleosidesRoleSTK11 geneSourceStaphylococcus aureusSystems BiologyTNF geneTestingTherapeuticTimeTissuesToll-like receptorsTraumaVisionVisualWild Type Mouseadductantimicrobialbacterial endophthalmitiscell growth regulationcell injurycytokinedisabilityimmunomodulatory therapiesintravitreal injectionlipid biosynthesismacrophagemetabolomicsmicrobialmitochondrial dysfunctionmonocytemouse modelneutrophilnew therapeutic targetnovel therapeutic interventionnovel therapeuticspathogenpathogenic bacteriaprotective effectresponsetissue repairtraffickingtranscriptomeupstream kinase
项目摘要
Project Summary
The role of myeloid cells such as neutrophils in providing host defense to microbial infections is well-
established; however, the contribution of monocytes/macrophages (Mϕ) to the pathophysiology of bacterial
endophthalmitis is less clear. Our preliminary studies revealed that Mϕ depletion results in increased
inflammatory mediators at the resolution phase, suggesting their involvement in the resolution of
endophthalmitis. The Mϕ perform multiple tasks, including sensing pathogens, tissue repair, and, in response
to host-derived mediators, they differentiate into distinct functional phenotypes; a feature termed "plasticity".
The "classically activated" Mϕ (M1) produce inflammatory cytokines and nitric oxide, contributing to host tissue
damage. Conversely, the "alternatively activated" Mϕ (M2) mediate tissue repair through the elimination of
damaged cells/tissue and the production of anti-inflammatory molecules to resolve inflammation. Therefore,
understanding the mechanisms governing the phenotypic switch of Mϕ can be utilized to develop novel
therapeutic strategies. Our transcriptome and metabolomics analyses of the bacteria-infected retina directed
us to the identification of adenosine monophosphate-activated protein kinase (AMPK), a metabolic gene, which
modulates the infiltrating myeloid cell phenotype in endophthalmitis. We discovered that mice with global
deletion (knockout) of AMPKα1 (KO) developed severe endophthalmitis and pathology compared to wild type
(WT) mice. Mϕ lacking AMPKα1 maintained a low metabolic state, even in the hyper-inflammatory state. To
precisely examine the role of AMPK in myeloid cells, we induced endophthalmitis in myeloid cell specific KO of
AMPKα1 (LysM-KO) and observed that LysM-KO displayed exacerbated inflammation and reduced retinal
function compared to WT mice, suggesting an essential role of AMPK in myeloid cells in the pathogenesis of
bacterial endophthalmitis. Building on these findings, we propose to test our central hypothesis that AMPK
exerts protective effects in bacterial endophthalmitis by modulating the polarization of infiltrating monocytes/Mϕ
to promote inflammation resolution and that metabolic reprograming is an underlying mechanism of the
monocytes/Mϕ phenotype switch. To test our hypothesis, in Aim 1, we will investigate the mechanisms
underlying reduced AMPK activity in bacterial endophthalmitis by examining the modification of LKB1 via
nitrosylation or chemical adduct formation. Aim 2 tests the hypothesis that AMPKα1 ablation enhances the
activation state of myeloid cells and maintains their proinflammatory (M1) state during the resolution phase of
the disease. In Aim 3, we will decipher the bioenergetic events, regulated by AMPK in Mϕ, that polarize and
maintain their pro-inflammatory nature. The anticipated results of this study will demonstrate that defective
AMPK activity in myeloid cells, mainly in monocytes/M impacts the resolution of endophthalmitis via
regulation of cellular metabolism. Also, it may provide novel therapeutic targets for the development of anti-
inflammatory therapies for endophthalmitis and other microbial infections.
项目摘要
髓样细胞(例如中性粒细胞)在为微生物感染提供宿主防御方面的作用是很好的
已确立的;然而,单核细胞/巨噬细胞(Mϕ)对细菌的病理生理的贡献
内膜炎不太清楚。我们的初步研究表明,M ϕ部署导致增加
在分辨率阶段的炎症介体,表明它们参与了分辨率
内脑膜。 M ϕ执行多个任务,包括感测病原体,组织修复以及响应
对于宿主衍生的介体,它们分为不同的功能表型。一个称为“可塑性”的功能。
“经典活化”的M ϕ(M1)产生炎症细胞因子和一氧化氮,有助于宿主组织
损害。相反,“替代激活”的M ϕ(M2)通过消除来介导组织修复
受损的细胞/组织和抗炎分子的产生以解决注射。所以,
了解管理M ϕ的表型转换的机制可以用于开发新颖的机制
治疗策略。我们针对细菌的视网膜的转录组和代谢组学分析
美国鉴定腺苷单磷酸激活的蛋白激酶(AMPK),一种代谢基因,该基因
调节内咽中浸润的髓样细胞表型。我们发现与全球的老鼠
与野生型相比
(wt)小鼠。缺乏AMPKα1的M ϕ保持低代谢状态,即使处于过度炎症状态。到
精确地检查了AMPK在髓样细胞中的作用,我们诱导了髓样细胞在特异性KO中的内脑炎
AMPKα1(LYSM-KO),并观察到Lysm-KO显示出加重的注射和视网膜的减少
与WT小鼠相比,功能表明AMPK在髓样细胞中的重要作用在
细菌性内膜。在这些发现的基础上,我们建议测试我们的中心假设,即AMPK
通过调节浸润单核细胞的极化/M ϕ的极化,对细菌发挥保护作用
促进注射分辨率和代谢重编程是
单核细胞/M ϕ表型开关。为了检验我们的假设,在AIM 1中,我们将研究机制
通过检查LKB1通过
硝基化或化学加合物形成。 AIM 2检验了AMPKα1消融的假设增强了
髓样细胞的激活状态并在分辨率阶段保持促炎(M1)状态
疾病。在AIM 3中,我们将破译由MDACH中AMPK调节的生物能量事件,该事件极化和
保持他们的促炎本质。这项研究的预期结果将证明有缺陷
髓样细胞中的AMPK活性,主要是单核细胞/M影响内脑膜的分辨率通过
调节细胞代谢。此外,它可能为抗抗 -
内度炎和其他微生物感染的炎症疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashok Kumar其他文献
Ashok Kumar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashok Kumar', 18)}}的其他基金
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 38.35万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 38.35万 - 项目类别:
Age-associated impaired executive function: Rescue by NMDA receptor upregulation
与年龄相关的执行功能受损:通过 NMDA 受体上调来挽救
- 批准号:
10033493 - 财政年份:2020
- 资助金额:
$ 38.35万 - 项目类别:
Role of ABCG1 in Zika virus induced chorioretinal atrophy
ABCG1 在寨卡病毒诱导的脉络膜视网膜萎缩中的作用
- 批准号:
9436896 - 财政年份:2018
- 资助金额:
$ 38.35万 - 项目类别:
Role of AMP-activated protein kinase in bacterial endophthalmitis - Diversity Supplement
AMP 激活蛋白激酶在细菌性眼内炎中的作用 - Diversity Supplement
- 批准号:
10206590 - 财政年份:2017
- 资助金额:
$ 38.35万 - 项目类别:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
靶向 NAD 代谢改善细菌性眼内炎
- 批准号:
10445516 - 财政年份:2017
- 资助金额:
$ 38.35万 - 项目类别:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
细菌性眼内炎的炎症消退机制
- 批准号:
10231125 - 财政年份:2017
- 资助金额:
$ 38.35万 - 项目类别:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
靶向 NAD 代谢改善细菌性眼内炎
- 批准号:
10621770 - 财政年份:2017
- 资助金额:
$ 38.35万 - 项目类别:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
细菌性眼内炎的炎症消退机制
- 批准号:
10002232 - 财政年份:2017
- 资助金额:
$ 38.35万 - 项目类别:
Toll-like receptors and bacterial endophthalmitis
Toll样受体与细菌性眼内炎
- 批准号:
8387011 - 财政年份:2010
- 资助金额:
$ 38.35万 - 项目类别:
相似国自然基金
Circ_MEF2D /miR-361/AMPK作用轴在血管内皮前体细胞治疗糖尿病足中的作用机制研究
- 批准号:81900431
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
Gadd45α调控脂代谢的分子机制研究
- 批准号:81702748
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
Sestrins 介导骨骼肌细胞自噬在有氧运动改善胰岛素抵抗中的作用机制
- 批准号:31571220
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
一磷酸腺苷(AMP)促进肌动球蛋白解离的作用机制研究
- 批准号:31571863
- 批准年份:2015
- 资助金额:68.0 万元
- 项目类别:面上项目
非内质网应激依赖性的真核生物翻译起始因子2alpha异常磷酸化在胆管癌进展和耐药中的作用及其机制
- 批准号:81472312
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Developmental Exposure to Maternal Overnutrition and Metformin on Offspring Mitochondrial Health and Beta Cell Function
发育期暴露于母亲营养过剩和二甲双胍对后代线粒体健康和 β 细胞功能的影响
- 批准号:
10601500 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Repurposing Metformin as a Treatment for Cocaine Use Disorder
重新利用二甲双胍治疗可卡因使用障碍
- 批准号:
10823844 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration
爪蟾中内胚层细胞集体细胞迁移的局部线粒体代谢活性
- 批准号:
10751722 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Cardioprotection against Adverse Side-Effects of Ibrutinib in Cancer Chemotherapy
癌症化疗中依鲁替尼不良副作用的心脏保护作用
- 批准号:
487140 - 财政年份:2023
- 资助金额:
$ 38.35万 - 项目类别:
Operating Grants